BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 30039763)

  • 1. Recent Updates on Glucokinase Activators and Glucokinase Regulatory Protein Disrupters for the Treatment of Type 2 Diabetes Mellitus.
    Kaushik A; Kaushik M
    Curr Diabetes Rev; 2019; 15(3):205-212. PubMed ID: 30039763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors.
    Lloyd DJ; St Jean DJ; Kurzeja RJ; Wahl RC; Michelsen K; Cupples R; Chen M; Wu J; Sivits G; Helmering J; Komorowski R; Ashton KS; Pennington LD; Fotsch C; Vazir M; Chen K; Chmait S; Zhang J; Liu L; Norman MH; Andrews KL; Bartberger MD; Van G; Galbreath EJ; Vonderfecht SL; Wang M; Jordan SR; VĂ©niant MM; Hale C
    Nature; 2013 Dec; 504(7480):437-40. PubMed ID: 24226772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glucokinase and glucokinase regulatory proteins as molecular targets for novel antidiabetic drugs].
    Rubtsov PM; Igudin EL; Tiulpakov AN
    Mol Biol (Mosk); 2015; 49(4):555-60. PubMed ID: 26299854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Developments in Medicinal Chemistry of Allosteric Activators of Human Glucokinase for Type 2 Diabetes Mellitus Therapeutics.
    Grewal AS; Lather V; Charaya N; Sharma N; Singh S; Kairys V
    Curr Pharm Des; 2020; 26(21):2510-2552. PubMed ID: 32286938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Small-Molecule Glucokinase Regulatory Protein Modulators That Restore Glucokinase Activity.
    Chen K; Michelsen K; Kurzeja RJ; Han J; Vazir M; St Jean DJ; Hale C; Wahl RC
    J Biomol Screen; 2014 Aug; 19(7):1014-23. PubMed ID: 24717911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A patent review of glucokinase activators and disruptors of the glucokinase--glucokinase regulatory protein interaction: 2011-2014.
    Filipski KJ; Pfefferkorn JA
    Expert Opin Ther Pat; 2014 Aug; 24(8):875-91. PubMed ID: 24821087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular targeting of the GK-GKRP pathway in diabetes.
    Hale C; Lloyd DJ; Pellacani A; VĂ©niant MM
    Expert Opin Ther Targets; 2015 Jan; 19(1):129-39. PubMed ID: 25324018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus.
    Grewal AS; Sekhon BS; Lather V
    Mini Rev Med Chem; 2014; 14(7):585-602. PubMed ID: 25052034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine alleviates hyperglycemia by targeting hepatic glucokinase in diabetic db/db mice.
    Li M; Dang Y; Li Q; Zhou W; Zuo J; Yao Z; Zhang L; Ji G
    Sci Rep; 2019 May; 9(1):8003. PubMed ID: 31142783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: a sequestration mechanism in metabolic regulation.
    Farrelly D; Brown KS; Tieman A; Ren J; Lira SA; Hagan D; Gregg R; Mookhtiar KA; Hariharan N
    Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14511-6. PubMed ID: 10588736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis for the role of glucokinase regulatory protein as the allosteric switch for glucokinase.
    Choi JM; Seo MH; Kyeong HH; Kim E; Kim HS
    Proc Natl Acad Sci U S A; 2013 Jun; 110(25):10171-6. PubMed ID: 23733961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of hepatocyte glucose metabolism by novel small molecule glucokinase activators.
    Brocklehurst KJ; Payne VA; Davies RA; Carroll D; Vertigan HL; Wightman HJ; Aiston S; Waddell ID; Leighton B; Coghlan MP; Agius L
    Diabetes; 2004 Mar; 53(3):535-41. PubMed ID: 14988235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric activators of glucokinase: potential role in diabetes therapy.
    Grimsby J; Sarabu R; Corbett WL; Haynes NE; Bizzarro FT; Coffey JW; Guertin KR; Hilliard DW; Kester RF; Mahaney PE; Marcus L; Qi L; Spence CL; Tengi J; Magnuson MA; Chu CA; Dvorozniak MT; Matschinsky FM; Grippo JF
    Science; 2003 Jul; 301(5631):370-3. PubMed ID: 12869762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects.
    Matschinsky FM; Zelent B; Doliba NM; Kaestner KH; Vanderkooi JM; Grimsby J; Berthel SJ; Sarabu R
    Handb Exp Pharmacol; 2011; (203):357-401. PubMed ID: 21484579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory protein.
    Slosberg ED; Desai UJ; Fanelli B; St Denny I; Connelly S; Kaleko M; Boettcher BR; Caplan SL
    Diabetes; 2001 Aug; 50(8):1813-20. PubMed ID: 11473043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An allosteric activator of glucokinase impairs the interaction of glucokinase and glucokinase regulatory protein and regulates glucose metabolism.
    Futamura M; Hosaka H; Kadotani A; Shimazaki H; Sasaki K; Ohyama S; Nishimura T; Eiki J; Nagata Y
    J Biol Chem; 2006 Dec; 281(49):37668-74. PubMed ID: 17028192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent clinical advances of glucokinase activators in the treatment of diabetes mellitus type 2.
    Li W; Zhang X; Sun Y; Liu Z
    Pharmazie; 2020 Jun; 75(6):230-235. PubMed ID: 32539915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus.
    Xu J; Lin S; Myers RW; Addona G; Berger JP; Campbell B; Chen HS; Chen Z; Eiermann GJ; Elowe NH; Farrer BT; Feng W; Fu Q; Kats-Kagan R; Kavana M; Malkani S; McMasters DR; Mitra K; Pachanski MJ; Tong X; Trujillo ME; Xu L; Zhang B; Zhang F; Zhang R; Parmee ER
    Bioorg Med Chem Lett; 2017 May; 27(9):2069-2073. PubMed ID: 28284804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylation of glucokinase regulatory protein decreases glucose metabolism by suppressing glucokinase activity.
    Park JM; Kim TH; Jo SH; Kim MY; Ahn YH
    Sci Rep; 2015 Dec; 5():17395. PubMed ID: 26620281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small Molecule Disruptors of the Glucokinase-Glucokinase Regulatory Protein Interaction: 5. A Novel Aryl Sulfone Series, Optimization Through Conformational Analysis.
    Tamayo NA; Norman MH; Bartberger MD; Hong FT; Bo Y; Liu L; Nishimura N; Yang KC; Tadesse S; Fotsch C; Chen J; Chmait S; Cupples R; Hale C; Jordan SR; Lloyd DJ; Sivits G; Van G; St Jean DJ
    J Med Chem; 2015 Jun; 58(11):4462-82. PubMed ID: 25914941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.